文献速递糖尿病骨质疏松与钙磷/甲状旁腺

糖尿病、骨骼与降糖药物:基础生物学

Diabetes, bone and glucose-lowering agents: basic biology.
PubMed 文献 · Diabetologia · 2017-04-22

本综述阐述糖尿病通过糖代谢紊乱、晚期糖基化终末产物(AGEs)毒性、骨微血管功能及肌肉内分泌功能受损影响骨骼的基础科学证据,讨论糖尿病对骨细胞分子机制、干细胞龛及骨折愈合的影响,并概述已获批降糖疗法的安全性及开发同时改善胰岛素敏感性和糖尿病骨病的单一疗法的可能性。

要点

  • 糖尿病患者的骨脆性常增加,但与低骨量或创伤严重程度不相关。
  • 1型和2型糖尿病中骨重建和骨转换均受损,导致骨材料质量缺陷。
  • AGEs毒性、骨微血管功能及肌肉内分泌功能受损参与糖尿病对骨骼的影响。

核心结论

  • 糖尿病通过糖代谢紊乱、AGEs毒性、骨微血管功能及肌肉内分泌功能受损影响骨骼,骨重建和骨转换在1型和2型糖尿病中均受损,导致骨材料质量缺陷。

研究设计与样本

  • 本综述为基础科学证据的叙述性综述,讨论糖尿病对骨骼影响的细胞与分子基础、对干细胞龛和骨折愈合的影响,以及降糖疗法安全性和单一疗法开发可能性。

主要发现

  • 糖尿病患者的骨脆性常伴随糖尿病出现,且与低骨量或创伤严重程度不相关。
  • 与骨质疏松性骨病患者相反,1型和2型糖尿病患者的骨重建和骨转换均受损,导致骨材料质量缺陷。
  • 糖尿病通过糖代谢受损、葡萄糖氧化衍生物(AGEs)毒性、骨微血管功能受损和肌肉内分泌功能受损影响骨骼。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Skeletal fragility often accompanies diabetes and does not appear to correlate with low bone mass or trauma severity in individuals with diabetes. Instead (and in contrast to those with osteoporotic bone disease), bone remodelling and bone turnover are compromised in both type 1 and type 2 diabetes, contributing to defective bone material quality. This review is one of a pair discussing the relationship between diabetes, bone and glucose-lowering agents; an accompanying review is provided in this issue of Diabetologia by Ann Schwartz (DOI: 10.1007/s00125-017-4283-6 ). This review presents basic science evidence that, alongside other organs, bone is affected in diabetes via impairments in glucose metabolism, toxic effects of glucose oxidative derivatives (advance glycation end-products [AGEs]), and via impairments in bone microvascular function and muscle endocrine function. The cellular and molecular basis for the effects of diabetes on bone are discussed, as is the impact of diabetes on the stem cell niche and fracture healing. Furthermore, the safety of clinically approved glucose-lowering therapies and the possibility of developing a single therapy that would be beneficial for both insulin sensitisation and diabetes bone syndrome are outlined.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Lecka-Czernik B. Diabetes, bone and glucose-lowering agents: basic biology. Diabetologia. 2017. PMID: 28434032. doi:10.1007/s00125-017-4269-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。